Meeting with Anniina Iskanius (Cabinet of Executive Vice-President Henna Virkkunen)

1 Apr 2025 · Preparedness and role of medicines

Meeting with Sebastian Tynkkynen (Member of the European Parliament)

1 Oct 2024 · EU:n terveysalan strategia, kehittäminen ja kasvu

Meeting with Alviina Alametsä (Member of the European Parliament)

25 Jun 2024 · Exchange of views

Meeting with Annukka Ojala (Cabinet of Commissioner Stella Kyriakides)

20 Jun 2024 · Pharma Reform

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

29 Mar 2024

Meeting with Henna Virkkunen (Member of the European Parliament, Rapporteur for opinion)

20 Feb 2024 · Medicinal products for human use

Meeting with Henna Virkkunen (Member of the European Parliament, Rapporteur for opinion) and Bayer AG

13 Oct 2023 · Medicinal products for human use

Meeting with Henna Virkkunen (Member of the European Parliament)

13 Dec 2022 · EU Health Policy

Meeting with Nils Torvalds (Member of the European Parliament)

13 Dec 2022 · Medicine regulation

Meeting with Sirpa Pietikäinen (Member of the European Parliament)

12 Dec 2022 · Upcoming EU's pharmaceutical legislation

Meeting with Jutta Urpilainen (Commissioner)

26 Sept 2022 · Health policy; pandemic response in partner countries.

Meeting with Mauri Pekkarinen (Member of the European Parliament)

26 Aug 2022 · Discussion on the meaning of EU innovation for the medical industry

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the European Health Data Space

15 Jul 2022

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EU) No 536/2014 of the European Parliament and of the Council as regards labelling requirements for unauthorised investigational and unauthorised auxiliary medicinal products

28 Jun 2022

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

22 Dec 2020

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

2 Jul 2020

Meeting with Marika Lautso-Mousnier (Cabinet of Vice-President Jyrki Katainen)

15 Oct 2019 · Smart health

Meeting with Marika Lautso-Mousnier (Cabinet of Vice-President Jyrki Katainen)

20 Mar 2019 · Health as engine for growth; health policies, data driven health care, industrial strategy

Meeting with Timo Pesonen (Acting Director-General Internal Market, Industry, Entrepreneurship and SMEs)

19 Mar 2019 · Exchange of views regarding future EU policies on smart health and wellbeing.

Meeting with Jyrki Katainen (Vice-President)

5 Oct 2018 · European research ecosystem and research of pharmaceuticals in the EU

Meeting with Kaius Kristian Hedberg (Cabinet of Commissioner Elżbieta Bieńkowska)

14 Mar 2018 · EU-IP-incentive review and SPC

Meeting with Timo Pesonen (Director-General Communication)

7 Mar 2018 · Discussions of European economy and on future of Europe